TG Therapeutics (TGTX) Stock: Climbing On Data

TG Therapeutics TGTX Stock News

TG Therapeutics Inc (NASDAQ: TGTX) is climbing in the market this morning, and for good reason. The company announced positive data from a Phase 2b clinical trial. As you could imagine, the news led to excitement among investors, pushing the stock on a run for the top. Today, we’ll talk about: The clinical data; what … Read more

Horizon Pharma (HZNP) Stock: Climbing On Trial Results

Horizon Pharma HZNP Stock News

Horizon Pharma PLC (NASDAQ: HZNP) is climbing early on in the trading session this morning, and for good reason. The company announced the results of a Phase 3 trial, meeting all primary and secondary endpoints.  As we have come to expect, the positive clinical data is sending the stock on a move upward. Today, we’ll … Read more

Intercept Pharmaceuticals (ICPT) Stock: Flying On Financial Results

Intercept Pharmaceuticals ICPT Stock News

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) is flying early on in the trading session this morning, and for good reason. The company announced its financial results for the fourth quarter and full year, exciting investors and sending the stock for the top. Today, we’ll talk about: The financial results; what we’re seeing from ICPT stock as … Read more

T2 Biosystems (TTOO) Stock: Climbing On Breakthrough Designation

T2 Biosystems TTOO Stock News

T2 Biosystems Inc (NASDAQ: TTOO) is having an incredibly strong start to the trading session this morning, and for good reason. Th company announced that it has been granted Breakthrough Device designation. As you would imagine, the news excited investors, pushing the stock on a run for the top. Today, we’ll talk about: The Breakthrough … Read more

Novavax (NVAX) Stock: Falling Hard On Trial Failure

Novavax NVAX Stock News

Novavax, Inc. (NASDAQ: NVAX) is having a horrible start to the trading session this morning, and for good reason. The company provided results from a Phase 3 trial that missed the mark, upsetting investors and sending the stock tumbling. Today, we’ll talk about: The data; what we’re seeing from NVAX stock as a result; and … Read more

Aceto (ACET) Stock: Here’s What’s Happening

Aceto ACET Stock News

Aceto Corporation (NASDAQ: ACET) is flying in the market today with gains that are better explained in multiples than percentages. However, if you’re digging for news, you’re not going to find any that’s less than a week old. So, what’s happening? Today, we’ll talk about: Why ACT stock is climbing; what we’re seeing from the … Read more

Sarepta Therapeutics (SRPT) Stock: Gaining On Positive Data

Sarepta Therapeutics SRPT Stock News

Sarepta Therapeutics Inc (NASDAQ: SRPT) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced positive clinical data. As you could imagine, the news excited investors who are pushing the stock for the top. Today, we’ll talk about: The new data; what we’re seeing from SRPT … Read more

Amarin Corporation (AMRN) Stock: Pops On Earnings

Amarin AMRN Stock News

Amarin Corporation plc (NASDAQ: AMRN), a company that has recently been the center of acquisition chatter, is having a strong start to the trading session in the market this morning. However, the gains are coming for an entirely different reason. The company announced its earnings, beating expectations and exciting investors. Today, we’ll talk about: The … Read more

Biocept (BIOC) Stock: Headed Up On Collaboration

Biocept BIOC Stock News

Biocept Inc (NASDAQ: BIOC) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced collaboration news, exciting investors and pushing the stock up. Today, we’ll talk about: The collaboration; what we’re seeing from BIOC stock as a result; and what we’ll be watching for ahead. BIOC … Read more

Midatech Pharma (MTP) Stock: Continues Skyward On Agreement Finalization

Midatech Pharma MTP Stock News

Midatech Pharma PLC-ADR (NASDAQ: MTP) is flying early on in the market again today. The stock is following up on gains in multiples that was saw yesterday. While no news has been released, there’s good reason for the gains. A document started to circulate yesterday showing that a key transaction has closed. This excited investors … Read more